Literature DB >> 8753773

Association of CD24 with the kinase c-fgr in a small cell lung cancer cell line and with the kinase lyn in an erythroleukemia cell line.

J A Zarn1, S M Zimmermann, M K Pass, R Waibel, R A Stahel.   

Abstract

Human CD24 is a highly glycosylated glycosylphosphatidylinositol-linked (GPI-linked) cell surface protein. GPI-linked proteins are involved in signal transduction mediated by members of the protein tyrosine kinase (PTK) family. Therefore we studied associated molecules providing the signaling capacity of CD24. Lysates of SW2 and K562 cells were analysed for expression of PTK of the c-src family by Western blotting. We identified c-fgr in SW2 lysates and c-fgr and also lyn in K562 lysates. To study a putative association of these PTK with CD24 we performed immunoprecipitations with the mAb SWA11 directed against CD24. Western analysis of the precipitates showed an association of c-fgr with CD24 in SW2 cells and lyn in K562 cells. We conclude that either c-fgr or lyn is physically associated with CD24 in a cell-type depending manner. An involvement of these complexes in signaling phenomenons of CD24 in small cell lung cancer and in leukaemias is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8753773     DOI: 10.1006/bbrc.1996.1184

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

2.  CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion.

Authors:  Niko Bretz; Aurelia Noske; Sascha Keller; Natalie Erbe-Hofmann; Thomas Schlange; Alexei V Salnikov; Gerd Moldenhauer; Glen Kristiansen; Peter Altevogt
Journal:  Clin Exp Metastasis       Date:  2011-10-08       Impact factor: 5.150

3.  CD24 interacts with and promotes the activity of c-src within lipid rafts in breast cancer cells, thereby increasing integrin-dependent adhesion.

Authors:  Petra Baumann; Wilko Thiele; Natascha Cremers; Santoshi Muppala; Justyna Krachulec; Markus Diefenbacher; Olivier Kassel; Giridhar Mudduluru; Heike Allgayer; Margaret Frame; Jonathan P Sleeman
Journal:  Cell Mol Life Sci       Date:  2011-06-28       Impact factor: 9.261

4.  Analysis of Recombinant CD24 Glycans by MALDI-TOF-MS Reveals Prevalence of Sialyl-T Antigen.

Authors:  Edwin Motari; Xincheng Zheng; Xiaodan Su; Yang Liu; Mamuka Kvaratskhelia; Michael Freitas; Peng George Wang
Journal:  Am J Biomed Sci       Date:  2009-01-01

Review 5.  CD24: from A to Z.

Authors:  Xianfeng Fang; Pan Zheng; Jie Tang; Yang Liu
Journal:  Cell Mol Immunol       Date:  2010-02-15       Impact factor: 11.530

6.  CD24 controls Src/STAT3 activity in human tumors.

Authors:  Niko P Bretz; Alexei V Salnikov; Claudia Perne; Sascha Keller; Xiaoli Wang; Claudia T Mierke; Mina Fogel; Natalie Erbe-Hofmann; Thomas Schlange; Gerhard Moldenhauer; Peter Altevogt
Journal:  Cell Mol Life Sci       Date:  2012-07-04       Impact factor: 9.261

7.  Increased neurogenesis in adult mCD24-deficient mice.

Authors:  Richard Belvindrah; Geneviève Rougon; Geneviève Chazal
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

Review 8.  Tumour biological aspects of CD24, a mucin-like adhesion molecule.

Authors:  G Kristiansen; M Sammar; P Altevogt
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

9.  Chemoenzymatic synthesis of the human CD52 and CD24 antigen analogues.

Authors:  Zhimeng Wu; Xueqing Guo; Guofeng Gu; Zhongwu Guo
Journal:  Org Lett       Date:  2013-10-22       Impact factor: 6.005

10.  Lyn is involved in CD24-induced ERK1/2 activation in colorectal cancer.

Authors:  Ning Su; Liang Peng; Bingqing Xia; Yingying Zhao; Angao Xu; Jing Wang; Xinying Wang; Bo Jiang
Journal:  Mol Cancer       Date:  2012-06-26       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.